Pasithea Therapeutics (KTTA) Other financing activities (2021 - 2024)
Historic Other financing activities for Pasithea Therapeutics (KTTA) over the last 4 years, with Q4 2024 value amounting to -$457600.0.
- Pasithea Therapeutics' Other financing activities changed N/A to -$457600.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$283664.0, marking a year-over-year change of. This contributed to the annual value of $471250.0 for FY2021, which is N/A changed from last year.
- Pasithea Therapeutics' Other financing activities amounted to -$457600.0 in Q4 2024.
- Over the past 5 years, Pasithea Therapeutics' Other financing activities peaked at $299665.0 during Q2 2021, and registered a low of -$836150.0 during Q4 2021.
- Moreover, its 4-year median value for Other financing activities was $24175.0 (2022), whereas its average is -$115021.3.
- The largest annual percentage gain for Pasithea Therapeutics' Other financing activities in the last 5 years was 6116.67% (2022), contrasted with its biggest fall of 5809.12% (2022).
- Pasithea Therapeutics' Other financing activities (Quarter) stood at -$836150.0 in 2021, then surged by 102.89% to $24175.0 in 2022, then changed by 0.0% to $24175.0 in 2023, then tumbled by 1992.86% to -$457600.0 in 2024.
- Its Other financing activities was -$457600.0 in Q4 2024, compared to $24175.0 in Q3 2023 and $24175.0 in Q3 2022.